A new eye implant, available at the New York Eye & Ear Infirmary of Mount Sinai, reduces the number of yearly eye injections for patients with wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The FDA-approved #SUSVIMO implant is a refillable device that continuously delivers medication over 6 months. NYEE is the first center to offer this treatment in New York City. Gennady Landa, MD, and his team performed their first case on May 7, 2025.
For more information on eye services at NYEE, visit: https://mshs.co/3S4qDnZ
#MacularDegeneration #Diabetes #DME